The Global Online Gambling and Betting Market is estimated to be valued at US$ 81.75 Bn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Online Gambling and Betting Market are Pfizer Inc., Novartis AG, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Merck KGaA, GSK plc., AbbVie Inc., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., AstraZeneca, AbCellera Biologics Inc., Molecular Depot LLC, DAIICHI SANKYO COMPANY, LIMITED., Abbott, Biogen, Thermo Fisher Scientific, Inc., Cell Signaling Technology, Inc, Intas Pharmaceuticals Ltd., Avantor Inc., UCB S.A., Merus N.V., GENEXTGENOMICS.COM, Biogenuix.

The Online Gambling And Betting Market Growth activities among the younger population coupled with the easy availability of high-speed internet and proliferation of smartphones have boosted the market growth in recent years. Various gamblers prefer the online medium over land-based gambling places for its round-the-clock access, comfort, and variety of options.

With growing digitization and internet penetration globally, companies in the online gambling and betting market are expanding their international presence and operations. Key players are investing in acquisitions and partnerships to expand into high potential regional markets and strengthen their product portfolios. Several countries have also legalized online gambling in recent times which has paved the way for larger international expansion of gambling operators.

Get More Insights on Online Gambling and Betting Market